Apitolisib

Apitolisib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T1916-2mg 2 mg

7 - 10 business days*

37.00€
TGM-T1916-5mg 5 mg

7 - 10 business days*

55.00€
TGM-T1916-10mg 10 mg

7 - 10 business days*

83.00€
TGM-T1916-25mg 25 mg

7 - 10 business days*

150.00€
TGM-T1916-50mg 50 mg

7 - 10 business days*

243.00€
TGM-T1916-100mg 100 mg

7 - 10 business days*

399.00€
 
Description: Apitolisib (RG 7422), an effective, class I PI3K inhibitor for PI3Kalpha(IC50=5 nM),... more
Product information "Apitolisib"
Description: Apitolisib (RG 7422), an effective, class I PI3K inhibitor for PI3Kalpha(IC50=5 nM), PI3Kbeta(IC50=27 nM), PI3Kdelta(IC50=7 nM), PI3Kgamma (IC50=14 nM), is used in trials study of solid cancers, breast cancer, prostate cancer, renal cell carcinoma, and endometrial carcinoma, among others. Target: Apoptosis, PI3K, mTOR. Smiles: C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1. References: Sutherlin DP, et al. J Med Chem, 2011, 54(21), 7579-7587.
Keywords: RG 7422, GNE 390, GDC-0980
Supplier: TargetMol
Supplier-Nr: T1916

Properties

Application: Targets phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta
MW: 498.6 D
Formula: C23H30N8O3S
Format: 32160405

Database Information

CAS : 1032754-93-0| Matching products
KEGG ID : K00922 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Apitolisib"
Write a review
or to review a product.
Viewed